Gabelli Funds LLC
- SEC CIK
- 0001081407
- Latest filing
- Aug 12, 2026
TXMD holding history
TherapeuticsMD, Inc. in every 13F filed by Gabelli Funds LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXMD overviewAll 13F holders of TXMDFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −12,000−100.0% | Sold out | Holders |
| Q2 2024 | 12,000 | $19.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 12,000 | $27.5K | <0.1% | −17,000−58.6% | Reduced | Holders |
| Q4 2023 | 29,000 | $65.3K | <0.1% | −2,000−6.5% | Reduced | Holders |
| Q3 2023 | 31,000 | $93.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 31,000 | $127.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 31,000 | $116.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 31,000 | $173.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 31,000 | $206.0K | <0.1% | −3,000−8.8% | Reduced | Holders |
| Q2 2022 | 34,000 | $338.0K | <0.1% | +34,000 | New | Holders |